Multicentric Retrospective Study of Perinatal Mortality (PM-PHD-NTM)

August 5, 2022 updated by: Nuria Torre-Monmany, Corporacion Parc Tauli

Clasificación y Factores de Riesgo de la Mortalidad Perinatatal

Background: Perinatal mortality ranges mortality from 22 gestational weeks up to the first 7 days of life and extended mortality goes up to 28 days of life. The perinatal mortality rate is the most sensitive index of the health status of women and their offspring and of the quality of maternal and child health services. Per our knowledge, there is no study that evaluates perinatal mortality in Catalonia, although household data are available from each hospital. Moreover, the official records usually do not match with the household surveys due to lack of clarity on the definitions. Aim: the aim of the study is to compare the WHO perinatal mortality classification following the ICD-PM in comparison with the used classification. Methodology: Multicentric retrospective study. Data from Sant Joan de Déu, Maternitat Clinic and Parc Taulí hospitals.

Study Overview

Status

Recruiting

Study Type

Observational

Enrollment (Anticipated)

468

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Barcelona
      • Sabadell, Barcelona, Spain, 08208
        • Recruiting
        • CorporacionPT
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 second to 4 weeks (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Perinatal

Description

Inclusion Criteria:

  • stillbirths more than 22 weeks of gestation
  • neonatal deaths up to 28 days of life

Exclusion Criteria:

- avortions more than 22 weeks of gestation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Retrospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
International Classification of Disease (10th Revision)- Perinatal Mortalitymaternal condition group
Time Frame: through study completion, an average of 1 year
The ICD-PM provides a standardised system for classifying perinatal mortality (including stillbirths) based on time of death (antepartum or intrapartum) into fetal and maternal causes thereby enabling comparisons within and between diverse settings and contexts
through study completion, an average of 1 year
International Classification of Disease (10th Revision)- Perinatal Mortality cause of death
Time Frame: through study completion, an average of 1 year
The ICD-PM provides a standardised system for classifying perinatal mortality (including stillbirths) based on time of death (antepartum or intrapartum) into fetal and maternal causes thereby enabling comparisons within and between diverse settings and contexts
through study completion, an average of 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Obstetric history
Time Frame: through study completion, an average of 1 year
number of pregnancies, number of total live births, number of deceased babies, number of stillbirths, number of neonatal deaths, number of abortions
through study completion, an average of 1 year
Mother's age
Time Frame: through study completion, an average of 1 year
age
through study completion, an average of 1 year
Type of pregnancy
Time Frame: through study completion, an average of 1 year
singleton, twins
through study completion, an average of 1 year
Antenatal care number of visits
Time Frame: through study completion, an average of 1 year
number
through study completion, an average of 1 year
Malaria profilaxis
Time Frame: through study completion, an average of 1 year
yes, no
through study completion, an average of 1 year
HIV status
Time Frame: through study completion, an average of 1 year
positive, negative
through study completion, an average of 1 year
Syphilis test
Time Frame: through study completion, an average of 1 year
positive, negative
through study completion, an average of 1 year
Mother's LMP
Time Frame: through study completion, an average of 1 year
date of the last menstrual period
through study completion, an average of 1 year
Date of birth
Time Frame: through study completion, an average of 1 year
date
through study completion, an average of 1 year
Gestational age
Time Frame: through study completion, an average of 1 year
weeks
through study completion, an average of 1 year
Place of delivery
Time Frame: through study completion, an average of 1 year
facility, home, road, others
through study completion, an average of 1 year
Onset of labour
Time Frame: through study completion, an average of 1 year
spontaneous, induced, cesarean before onset
through study completion, an average of 1 year
Fetal heart sounds on admission
Time Frame: through study completion, an average of 1 year
yes, no
through study completion, an average of 1 year
Partograph used
Time Frame: through study completion, an average of 1 year
yes, no
through study completion, an average of 1 year
Mode of delivery
Time Frame: through study completion, an average of 1 year
vaginal, vaginal assisted, cesarean
through study completion, an average of 1 year
Time between decision for action and birth
Time Frame: through study completion, an average of 1 year
not applicable, < 30 min, 30 - 60 min, > 60 min
through study completion, an average of 1 year
Apgar Score
Time Frame: through study completion, an average of 1 year
Apgar Score (min 0, max 10). Higher scores means better outcome
through study completion, an average of 1 year
Resuscitation
Time Frame: through study completion, an average of 1 year
not necessary, suction, stimulation, ventilation, cardiac compressions, not done
through study completion, an average of 1 year
Sex of baby
Time Frame: through study completion, an average of 1 year
male, female, unknown
through study completion, an average of 1 year
Birth weight
Time Frame: through study completion, an average of 1 year
grams
through study completion, an average of 1 year
Date of death
Time Frame: through study completion, an average of 1 year
Date
through study completion, an average of 1 year
Type of death
Time Frame: through study completion, an average of 1 year
neonatal, intrapartum or antepartum or unknown timing stillbirth
through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

August 5, 2022

Primary Completion (Anticipated)

December 31, 2022

Study Completion (Anticipated)

December 31, 2024

Study Registration Dates

First Submitted

July 24, 2022

First Submitted That Met QC Criteria

August 5, 2022

First Posted (Actual)

August 8, 2022

Study Record Updates

Last Update Posted (Actual)

August 8, 2022

Last Update Submitted That Met QC Criteria

August 5, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stillbirth

3
Subscribe